SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Magellan Health is a healthcare plans business based in the US. Magellan Health shares (MGLN) are listed on the NASDAQ and all prices are listed in US Dollars. Magellan Health employs 9,000 staff and has a trailing 12-month revenue of around $4.8 billion.
SoFi Invest
tastyworks
Latest market close | $0.00 |
---|---|
52-week range | $0.00 - $0.00 |
50-day moving average | $94.68 |
200-day moving average | $94.47 |
Wall St. target price | $95.00 |
PE ratio | 8.4858 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $11.19 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0 from 2022-01-19
1 week (2023-01-17) | nan% |
---|---|
1 month (2022-12-24) | nan% |
3 months (2022-10-24) | nan% |
6 months (2022-07-24) | nan% |
1 year (2022-01-24) | nan% |
---|---|
2 years (2021-01-28) | -100.00% |
3 years (2020-01-28) | 74.3 |
5 years (2018-01-26) | 101.4 |
Valuing Magellan Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Magellan Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Magellan Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Magellan Health shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Magellan Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Magellan Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Magellan Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $86.8 million.
The EBITDA is a measure of a Magellan Health's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $4.8 billion |
---|---|
Operating margin TTM | 0.6% |
Gross profit TTM | $120.8 million |
Return on assets TTM | 0.54% |
Return on equity TTM | -0.16% |
Profit margin | 6.26% |
Book value | $73.44 |
Market capitalisation | $2.5 billion |
TTM: trailing 12 months
We're not expecting Magellan Health to pay a dividend over the next 12 months.
Magellan Health's shares were split on a 1:308 basis on 5 January 2004. So if you had owned 308 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Magellan Health shares – just the quantity. However, indirectly, the new 30700% higher share price could have impacted the market appetite for Magellan Health shares which in turn could have impacted Magellan Health's share price.
Over the last 12 months, Magellan Health's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Magellan Health's is 1.0353. This would suggest that Magellan Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Magellan Health, Inc. , together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.